In line with this, it has been shown that FGF-23 production/cleavage can be triggered by erythropoietin, iron deficiency, anemia, and inflammation [8–10], factors that also play a role in MDS [11, 12]. The gene discussed is FGF23; the disease is myelodysplastic syndrome.